基于多参数MRI的列线图预测前列腺癌包膜外侵犯和精囊侵犯的外部验证
本研究外部验证了Gandaglia等基于多参数MRI和MRI靶向活检开发的预测前列腺癌根治术后包膜外侵犯(ECE)和精囊侵犯(SVI)的列线图,纳入566例经MRI靶向活检诊断并接受根治性前列腺切除术的患者。最终病理显示37%和12%的患者分别存在ECE和SVI。与MSKCC模型和Partin表相比,该列线图对ECE的区分度较高(71.8% vs 69.8%,p=0.3;71.8% vs 61.3%,p<0.001),但对SVI的区分度相当(68.5% vs 70.4% vs 67.8%,p≥0.6),且校准略高估。
要点
- 列线图预测ECE的区分度优于Partin表,但与MSKCC模型无显著差异。
- 列线图预测SVI的区分度与MSKCC模型和Partin表相当,校准略高估。
- 基于MRI的列线图未明显改善患者选择,临床实用性有限。
核心结论
- 该列线图外部验证性能不如预期,MRI的加入未明确改善患者选择。
- 作者提出经重新校准的ECE预测列线图更新版,需另一外部集验证。
研究设计与样本
- 多中心外部验证研究,纳入566例经MRI靶向活检诊断并接受根治性前列腺切除术的前列腺癌患者。
主要发现
- 最终病理显示37%患者有ECE,12%有SVI。
- ECE预测:列线图区分度71.8%,MSKCC模型69.8%(p=0.3),Partin表61.3%(p<0.001)。
- SVI预测:列线图、MSKCC模型和Partin表的区分度分别为68.5%、70.4%、67.8%(p≥0.6)。
- ECE预测中,概率阈值>30%时列线图与MSKCC模型校准相似且净获益相当。
- SVI预测中,概率阈值>7.5%时列线图有净获益,但校准图显示轻微高估。
临床怎么用
- 在临床决策中参考该列线图预测ECE和SVI时,需注意其外部验证性能有限。
- MRI结合MRI靶向活检的列线图未明确优于基于临床参数的现有模型。
局限性
- 列线图性能不如预期乐观,需重新校准。
- 更新版列线图需另一外部数据集验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The nomogram reported by Gandaglia et al (The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging-targeted and concomitant systematic biopsies for the prediction of adverse pathological features in prostate cancer patients undergoing radical prostatectomy. Eur Urol 2020;77:733-41) predicting extracapsular extension (ECE) or seminal vesicle invasion (SVI) has been developed using multiparametric magnetic resonance imaging (MRI) parameters and MRI-targeted biopsy. We aimed to validate this nomogram externally by analyzing 566 patients harboring prostate cancer diagnosed on MRI-targeted biopsy followed by radical prostatectomy. At final pathology, 37% and 12% patients had ECE and SVI, respectively. Performance of the nomogram, in comparison with the Memorial Sloan Kettering Cancer Center (MSKCC) model and Partin tables, was evaluated using discrimination, calibration, and decision curve analysis. Regarding ECE prediction, the nomogram showed higher discrimination (71.8% vs 69.8%, p = 0.3 and 71.8% vs 61.3%, p < 0.001), and similar miscalibration and net benefit for probability threshold above 30% when compared with MSKCC model and Partin tables, respectively. Performance of the nomogram with regard to SVI was comparable in terms of discrimination (68.5% vs 70.4% vs 67.8%, p ≥ 0.6), presenting a slight overestimation on calibration plots and a net benefit for probability threshold above 7.5%. This is the first multicentric study that externally validates a nomogram predicting ECE and SVI in patients diagnosed with MRI-targeted biopsy. Its performance was less optimistic than expected, and implementation of MRI in this setting was not associated with a clear improvement in patient selection and clinical usefulness when compared with available models. We proposed an updated version of the nomogram predicting ECE using the recalibration method, which leads to an improvement in its performance and needs to be validated in another external set. PATIENT SUMMARY: We validate a prediction tool based on multiparametric magnetic resonance imaging (MRI) parameters and MRI-targeted biopsy predicting extracapsular extension and seminal vesicle invasion at radical prostatectomy. An improvement of patient selection was not clearly demonstrated when compared with available models based on clinical parameters, and implementation of MRI in this setting still needs to be clarified.
引用
- Diamand R, Ploussard G, Roumiguié M, et al. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol. 2020. PMID: 33023770. doi:10.1016/j.eururo.2020.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。